Supportive Care in Cancer

, Volume 12, Issue 6, pp 421–431 | Cite as

The treatment of lymphedema related to breast cancer: a systematic review and evidence summary

  • Lyn Kligman
  • Rebecca K. S. Wong
  • Mary Johnston
  • Nancy S. Laetsch
  • Members of the Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-based Care
Review Article


Goals of work

To provide an evidence summary report on the question: What are the treatment options for women with lymphedema following treatment for breast cancer?


Cancer Care Ontario’s Supportive Care Guidelines Group (SCGG) employed systematic review methodology to produce an evidence summary on this topic. Evidence-based opinions were formulated to guide clinical decision making, and a formal external review process was conducted to validate the relevance of these opinions for Ontario practitioners.


The systematic review search strategy identified ten randomized controlled trials which form the basis of this evidence summary report. Four key opinions offered by the SCGG are outlined below. Responses from the practitioner feedback process supported the validity of these opinions in Ontario. (1) There is some evidence to suggest that compression therapy and manual lymphatic drainage may improve established lymphedema, but further studies are needed. Compression garments should be worn from morning to night and be removed at bedtime. Patients should be advised that lymphedema is a lifelong condition and that compression garments must be worn on a daily basis. Patients can expect stabilization and/or modest improvement of edema with the use of the garment in the prescribed fashion. (2) There is no current evidence to support the use of medical therapies, including diuretics. (3) Additional efforts to define relevant clinical outcomes for the assessment of patients with lymphedema would be valuable. (4) These opinions are appropriate for patients with more than mild lymphedema, where the signs and symptoms are considered significant from the patients’ perspective.


Lymphedema Breast neoplasms Systematic review Evidence summary Lymphedema management 



The Supportive Care Guidelines Group would like to thank Ms. Lyn Kligman, Dr. Rebecca Wong, Ms. Mary Johnston, and Ms. Nancy Laetsch for taking the lead in drafting and revising this evidence summary report.


  1. 1.
    Anderson L, Hojris I, Erlandsen M, et al (2000) Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage: a randomized study. Acta Oncol 39:399–405CrossRefPubMedGoogle Scholar
  2. 2.
    Badger C, Seers K, Preston N, et al (2002) Physical therapies for reducing and controlling lymphoedema of the limbs (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, OxfordGoogle Scholar
  3. 3.
    Bertelli G, Venturini M, Forno G, et al (1991) Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. Ann Oncol 2:575–578Google Scholar
  4. 4.
    Blanchard DK, Donohue JH, Reynolds C, et al (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–487CrossRefPubMedGoogle Scholar
  5. 5.
    Browman GP, Levine MN, Mohide EA, et al (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502–512PubMedGoogle Scholar
  6. 6.
    Browning C (1997) The management of lymphoedema. In: Redman S, Pillar C, Turner J, Boyle F (eds) Lymphoedema: prevalence, risk factors and management: a review of research. NHMRC National Breast Cancer Centre, SydneyGoogle Scholar
  7. 7.
    Casley-Smith JR, Morgan RG, Piller NB (1993) Treatment of lymphedema of the arms and legs with 5,6-benzo-pyrone. N Engl J Med 329:1158–1163CrossRefPubMedGoogle Scholar
  8. 8.
    Dini D, Del Mastro L, Gozz A, et al (1998) The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol 9:187–191Google Scholar
  9. 9.
    Erickson VS, Pearson ML, Ganz PA, et al (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111CrossRefPubMedGoogle Scholar
  10. 10.
    Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMedGoogle Scholar
  11. 11.
    Harris SR, Hugi MR, Olivotto IA, et al, for the Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 164:191–199PubMedGoogle Scholar
  12. 12.
    Hoe AL, Iven D, Royle GT, et al (1992) Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79:261–262PubMedGoogle Scholar
  13. 13.
    Hornsby R (1995) The use of compression to treat lymphoedema. Prof Nurs 11:127–128Google Scholar
  14. 14.
    Howell D, Ezzo J, Tuppo K, et al (2002) Complete decongestive therapy for lymphedema following breast cancer treatment (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, OxfordGoogle Scholar
  15. 15.
    Jacobson JS, Workman SB, Kronenberg F (2000) Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 18:668–683PubMedGoogle Scholar
  16. 16.
    Jani AB, Basu A, Heimann R, et al (2003) Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis. Cancer 97:359–366CrossRefPubMedGoogle Scholar
  17. 17.
    Johansson K, Lie E, Ekdahl C, et al (1998) A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology 31:56–64PubMedGoogle Scholar
  18. 18.
    Kissin MW, Querci della Roveret G, Easton D, et al (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:680–684Google Scholar
  19. 19.
    Logan V (1995) Incidence and prevalence of lymphedema: a literature review. J Clin Nurs 4:213–219PubMedGoogle Scholar
  20. 20.
    Loprinzi CL, Kugler JW, Sloan JA, et al (1999) Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340:346–350CrossRefPubMedGoogle Scholar
  21. 21.
    Markowski J, Wilcox J, Helm P (1981) Lymphedema incidence after specific postmastectomy therapy. Arch Phys Med Rehabil 62:449–452PubMedGoogle Scholar
  22. 22.
    Megens A, Harris SR (1998) Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther 78:1302–1311PubMedGoogle Scholar
  23. 23.
    Oncology Nursing Society (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Press, Pittsburgh, PA (summary at Scholar
  24. 24.
    Pain SJ, Purushotham AD (2000) Lymphoedema following surgery for breast cancer. Br J Surg 87:1128–1141Google Scholar
  25. 25.
    Pecking A, Lasry S, Boudinet A, et al (1988) Post surgical physiotherapeutic treatment: interest in secondary upper limb lymphedemas prevention. Prog Lymphology 11:562–564Google Scholar
  26. 26.
    Pecking AP, Fevrier B, Wargon C, et al (1997) Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 48:93–98PubMedGoogle Scholar
  27. 27.
    Piller NB, Morgan RG, Casley-Smith JR (1988) A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzopyrones) in the treatment of the arms and legs. Br J Plast Surg 41:20–27PubMedGoogle Scholar
  28. 28.
    Ramos SM, O’Donnell LS, Knight G (1999) Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg 178:311–315CrossRefPubMedGoogle Scholar
  29. 29.
    Schijven MP, Vingerhoets AJ, Rutten HJ, et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350CrossRefPubMedGoogle Scholar
  30. 30.
    Scottish Intercollegiate Guidelines Network (1998) Breast cancer in women (publication no. 29). Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Lyn Kligman
    • 1
  • Rebecca K. S. Wong
    • 2
  • Mary Johnston
    • 3
  • Nancy S. Laetsch
    • 3
  • Members of the Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-based Care
  1. 1.Pain and Symptom Management Team, Supportive Care ProgramLondon Regional Cancer CentreLondonCanada
  2. 2.Department of Radiation OncologyPrincess Margaret HospitalTorontoCanada
  3. 3.Cancer Care Ontario Program in Evidence-Based CareMcMaster UniversityHamiltonCanada

Personalised recommendations